An investigation for investors in Transenterix Inc (NYSEMKT:TRXC) shares over potential securities laws violations by Transenterix was announced and NYSEMKT:TRXC stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 04/26/2016 -- Transenterix Inc is under investigation over potential securities laws violations. The investigation was announced on behalf of investors of Transenterix Inc shares in connection certain financial statements.
Investors who purchased shares of Transenterix Inc(NYSEMKT:TRXC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Transenterix regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On April 20, 2016, Transenterix Inc announced that the Food and Drug Administration ("FDA") notified Transenterix Inc on April 19, 2016 of its determination that the "SurgiBot™ System does not meet the criteria for substantial equivalence based upon the data and information submitted by TransEnterix in its 510(k) submission." Shares of Transenterix Inc(NYSEMKT:TRXC declined to a slow as $1.28 per share on April 21, 2016.
Those who purchased shares of Transenterix Inc have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com